Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Febrile Neutropenia
Interventions: DRUG: PEGCSF first level prophylactic use|DRUG: PEGCSF second level prophylactic use
Sponsor: Zhejiang Cancer Hospital